Considerations in sirolimus use in the early and late post-transplant periods.
about
Potential use of rapamycin in HIV infectionSafety and tolerability of the T-cell depletion protocol coupled with anakinra and etanercept for clinical islet cell transplantation.Sirolimus and post transplant Cy synergistically maintain mixed chimerism in a mismatched murine model.The safety of calcineurin inhibitors for kidney-transplant patients.Comparative study of rapamycin and temsirolimus demonstrates superimposable anti-tumour potency on prostate cancer cells.
P2860
Considerations in sirolimus use in the early and late post-transplant periods.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Considerations in sirolimus use in the early and late post-transplant periods.
@en
Considerations in sirolimus use in the early and late post-transplant periods.
@nl
type
label
Considerations in sirolimus use in the early and late post-transplant periods.
@en
Considerations in sirolimus use in the early and late post-transplant periods.
@nl
prefLabel
Considerations in sirolimus use in the early and late post-transplant periods.
@en
Considerations in sirolimus use in the early and late post-transplant periods.
@nl
P2093
P2860
P1476
Considerations in sirolimus use in the early and late post-transplant periods.
@en
P2093
A Osama Gaber
Erin N Elliott
Lillian W Gaber
Richard J Knight
Samir J Patel
P2860
P304
P356
10.1517/14740330903037156
P407
P577
2009-07-01T00:00:00Z